Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × olokizumab × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Arthritis, Rheumatoid 1

Interventions

Rituximab 237 Cyclophosphamide 193 Vincristine 165 Doxorubicin 151 Prednisone 127 Methotrexate 80 Etoposide 79 Cytarabine 78 Dexamethasone 72 Radiotherapy 60 Bendamustine Hydrochloride 58 Mercaptopurine 46 pegaspargase 41 Lenalidomide 41 Prednisolone 38 Filgrastim 38 ibrutinib 37 Bleomycin 37 fludarabine 36 Daunorubicin 35 obinutuzumab 34 Asparaginase 33 Leucovorin 29 venetoclax 28 Granulocyte Colony-Stimulating Factor 27 Chlorambucil 27 Calcium Dobesilate 27 Gemcitabine 26 Vinblastine 25 Thioguanine 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03120949 2023-10-12

CREDO 4

R-Pharm

Phase 3 Completed

2,106 enrolled 30 charts

Arthritis, Rheumatoid, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡